A model of cancer stem cells derived from mouse induced pluripotent stem cells

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Chen, Ling ^a,b,c   Kasai, Tomonari ^a   Li, Yueguang ^d   Sugii, Yuh ^a   Jin, Guoliang ^a   Okada, Masashi ^a   Vaidyanath, Arun ^a   Mizutani, Akifumi ^a   Satoh, Ayano ^a   Kudoh, Takayuki ^a   Hendrix, Mary J C ^e   Salomon, David S ^f   Fu, Li ^g   Seno, Masaharu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c Tianjin Central Hospital of Gynecology Obstetrics   (China)

^d TIANJIN FOURTH CENTRAL HOSPITAL   (China)

^e NORTHWESTERN UNIVERSITY   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; HOMEODOMAIN PROTEIN; NANOG PROTEIN, MOUSE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALB/C NUDE MOUSE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENICITY; CELL SELF-RENEWAL; CONTROLLED STUDY; EMBRYONAL CARCINOMA; FEEDER CELL; FEMALE; IMMUNOHISTOCHEMISTRY; IN VIVO CULTURE; INDUCED PLURIPOTENT STEM CELL; LEWIS CARCINOMA; MARKER GENE; MELANOMA B16; MOUSE; NONHUMAN; SPHEROID CELL; SUSPENSION CELL CULTURE; TUMOR MICROENVIRONMENT; TUMOR SPHEROID; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIUM; CYTOLOGY; GENETIC MARKER; GENETICS; PLURIPOTENT STEM CELL; TUMOR CELL LINE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; GENETIC MARKERS; GREEN FLUORESCENT PROTEINS; HOMEODOMAIN PROTEINS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, INBRED BALB C; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; TUMOR MICROENVIRONMENT;

EID: 84864830414     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033544     Document Type: Article

References (40)

1. Zhao RC, Zhu YS, Shi Y (2008) New hope for cancer treatment: exploring the distinction between normal adult stem cells and cancer stem cells. Pharmacol Ther 119: 74-82.
2. Marotta LL, Polyak K (2009) Cancer stem cells: a model in the making. Curr Opin Genet Dev 19: 44-50.
3. Booth BW, Boulanger CA, Anderson LH, Smith GH (2011) The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells. Oncogene 30: 679-689.
4. Booth BW, Mack DL, Androutsellis-Theotokis A, McKay RD, Boulanger CA, et al. (2008) The mammary microenvironment alters the differentiation repertoire of neural stem cells. Proc Natl Acad Sci U S A 105: 14891-14896.
5. Boulanger CA, Mack DL, Booth BW, Smith GH (2007) Interaction with the mammary microenvironment redirects spermatogenic cell fate in vivo. Proc Natl Acad Sci U S A 104: 3871-3876.
6. Boulanger CA, Smith GH (2009) Reprogramming cell fates in the mammary microenvironment. Cell Cycle 8: 1127-1132.
7. Abbott DE, Bailey CM, Postovit LM, Seftor EA, Margaryan N, et al. (2008) The epigenetic influence of tumor and embryonic microenvironments: how different are they? Cancer Microenviron 1: 13-21.
8. Tzukerman M, Rosenberg T, Reiter I, Ben-Eliezer S, Denkberg G, et al. (2006) The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts. Cancer Res 66: 3792-3801.
9. Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, et al. (2008) Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci U S A 105: 4329-4334.
10. Costa FF, Seftor EA, Bischof JM, Kirschmann DA, Strizzi L, et al. (2009) Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment. Epigenomics 1: 387-398.
11. Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317.
12. Niwa A, Umeda K, Chang H, Saito M, Okita K, et al. (2009) Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors. J Cell Physiol 221: 367-377.
13. Onorati M, Camnasio S, Binetti M, Jung CB, Moretti A, et al. (2010) Neuropotent self-renewing neural stem (NS) cells derived from mouse induced pluripotent stem (iPS) cells. Mol Cell Neurosci 43: 287-295.
14. Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, et al. (2008) Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 18: 498-506.
15. Alipio Z, Liao W, Roemer EJ, Waner M, Fink LM, et al. (2010) Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)- derived pancreatic beta-like cells. Proc Natl Acad Sci U S A 107: 13426-13431.
16. Yamanaka S (2009) A fresh look at iPS cells. Cell 137: 13-17.
17. Stadtfeld M, Hochedlinger K (2010) Induced pluripotency: history, mechanisms, and applications. Genes Dev 24: 2239-2263.
18. Hanley J, Rastegarlari G, Nathwani AC (2010) An introduction to induced pluripotent stem cells. Br J Haematol 151: 16-24.
19. Miyoshi N, Ishii H, Sekimoto M, Haraguchi N, Doki Y, et al. (2010) Properties and identification of cancer stem cells: a changing insight into intractable cancer. Surg Today 40: 608-613.
20. Kuroda Y, Kitada M, Wakao S, Nishikawa K, Tanimura Y, et al. (2010) Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci U S A 107: 8639-8643.
21. Al-Hajj M, Clarke MF (2004) Self-renewal and solid tumor stem cells. Oncogene 23: 7274-7282.
22. Ruiz-Vela A, Aguilar-Gallardo C, Simón C (2009) Building a framework for embryonic microenvironments and cancer stem cells. Stem Cell Rev 5: 319-327.
23. Baiocchi M, Biffoni M, Ricci-Vitiani L, Pilozzi E, De Maria R (2010) New models for cancer research: human cancer stem cell xenografts. Curr Opin Pharmacol 10: 380-384.
24. Shen Q, Wang Y, Kokovay E, Lin G, Chuang SM, et al. (2008) Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions. Cell Stem Cell 3: 289-300.
25. Huang S, Bucana CD, Van Arsdall M, Fidler IJ (2002) Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells. Oncogene 21: 2504-2512.
26. Shackleton M (2010) Normal stem cells and cancer stem cells: similar and different. Semin Cancer Biol 20: 85-92.
27. Scaffidi P, Misteli T (2011) In vitro generation of human cells with cancer stem cell properties. Nat Cell Biol 13: 1051-1061.
28. Markoulaki S, Hanna J, Beard C, Carey BW, Cheng AW, et al. (2009) Transgenic mice with defined combinations of drug-inducible reprogramming factors. Nat Biotechnol 27: 169-171.
29. Morimoto J, Imai S, Taniguchi Y, Tsubra Y, Hosick HL (1987) Establishment and characterization of a new murine mammary tumor cell line, BALB/c-MC. In Vitro Cell Dev Biol 23: 755-758.
30. Pasi CE, Dereli-Öz A, Negrini S, Friedli M, Fragola G, et al. (2011) Genomic instability in induced stem cells. Cell Death Differ 18: 745-753.
31. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, et al. (2011) Copy number variation and selection during reprogramming to pluripotency. Nature 471: 58-62.
32. Gore A, Li Z, Fung H-L, Young JE, Agarwal S, et al. (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature 629: 205-237.
33. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, et al. (2011) Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8: 106-118.
34. Schorey JS, Bhatnagar S (2008) Exosome function: From tumor immunology to pathogen biology. Traffic 9: 871-881.
35. Al-Nedawi K, Meehan B, Rak J (2009) Microvesicles: messengers and mediators of tumor progression. Cell Cycle 8: 2014-2018.
36. Park JE, Tan HS, Datta A, Lai RC, Zhang H, et al. (2010) Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics 9: 1085-1099.
37. Hood JL, Pan H, Lanza GM, Wickline SA (2009) Paracrine induction of endothelium by tumor exosomes. Lab Invest 89: 1317-1328.
38. Bar J, Feniger-Barish R, Lukashchuk N, Shaham H, Moskovits N, et al. (2009) Cancer cells suppress p53 in adjacent fibroblast. Oncogene 28: 933-936.
39. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, et al. (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270.
40. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.